Publications by authors named "L Musso"

Claim this Profile
C
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191].
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Lauren Musso

Gynecol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retargeting Gram-Positive-Only Adarotene-Derived Antibacterials to Broad-Spectrum Antibiotics.
Salvatore Princiotto, Luigi Cutarella, Alessandra Fortuna, Marta Mellini, Bruno Casciaro, Loana Musso

Antibiotics (Basel)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When Sutures Fail: Extrusion of an Inspire Device and a Hip Prosthesis in the Same Patient.
Kalin R Sorenson, Cameron Robins, Keala Verigan, Nicholas Gerber, Louis Musso

Cureus· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer.
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Lauren Musso

Gynecol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation.
Laura Musso, Cristina Maltese, Giulio Beretta, Ilaria Patelli, Stefano Raffa

Pharmaceuticals (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis